罗马V全球流行病学调查:脑肠轴互动障碍患病率及与罗马IV比较
在15个国家28,771名成人中开展罗马V诊断问卷的互联网调查,至少一种脑肠轴互动障碍(DGBI)患病率为40.9%,与罗马IV的40.5%相似;女性患病率更高且随年龄增长而下降。功能性消化不良(8.1%)、未分类肠道障碍(9.6%)、慢性便秘(8.9%)和肠易激综合征(8.5%)为常见类型。
要点
- 罗马V标准下DGBI全球患病率为40.9%,与罗马IV的40.5%基本一致。
- 功能性消化不良是最常见的胃十二指肠DGBI(8.1%)。
- 新纳入的腹部偏头痛和无法嗳气综合征患病率分别为5.1%和1.4%。
核心结论
- 罗马V标准下DGBI全球患病率与罗马IV一致,支持DGBI患病率的有效性并重申其高全球负担。
研究设计与样本
- 基于人群的互联网调查,在15个国家纳入28,771名成人,使用罗马V诊断问卷,并与罗马IV全球流行病学数据比较。
主要发现
- 至少一种DGBI的罗马V患病率为40.9%,罗马IV为40.5%。
- 女性和年轻年龄与DGBI患病率较高相关。
- 食管障碍中最常见为功能性吞咽困难(4.1%)。
- 肠道障碍中最常见为未分类肠道障碍(9.6%),其次为慢性便秘(8.9%)和IBS(8.5%)。
- 肛门直肠障碍中最常见为痉挛性肛痛(7.3%)。
关键数值与推荐
- 罗马V标准下最常见的胃十二指肠障碍为功能性消化不良,患病率8.1%。
- 新DGBI中腹部偏头痛患病率5.1%,无法嗳气综合征患病率1.4%。
临床怎么用
- 临床可依据罗马V标准识别高负担的DGBI,关注女性及年轻人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The recently published Rome V adult diagnostic criteria facilitated an updated epidemiological survey of disorders of gut-brain interaction (DGBI). OBJECTIVE: We aimed to describe the global epidemiology of DGBI using the Rome V criteria and compare it with the Rome IV Rome Foundation Global Epidemiology Study. METHODS: A population-based Internet survey of 28,771 adults was conducted in 15 countries using the Rome V diagnostic questionnaire. DGBI prevalence was determined and compared with the Rome IV data. Multivariable logistic regression models were used to examine associations of demographic factors to Rome V DGBI status in the global population and to assess potentially associated clinical factors. RESULTS: The surveys yielded similar results. The prevalence of at least one DGBI using the Rome V criteria was 40.9%, compared with 40.5% for Rome IV. In both, the prevalence was higher among females and decreased with increasing age. In the Rome V sample (25 DGBI), the most prevalent oesophageal disorder was functional dysphagia at 4.1%, the most prevalent gastroduodenal disorder was functional dyspepsia at 8.1%, unclassified bowel disorder was the most prevalent bowel disorder (9.6%), followed by chronic constipation (8.9%) and IBS (8.5%) and proctalgia fugax was the most prevalent anorectal disorder (7.3%). The prevalence rates for two new DGBI were 5.1% for abdominal migraine and 1.4% for inability to belch syndrome. CONCLUSION: The Rome V global prevalence of DGBI is consistent with Rome IV. This bolsters confidence in the validity of prevalence rates for DGBI and reaffirms their high global burden.
引用
- Sperber AD, Hreinsson JP, Simrén M, et al. Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study. Gut. 2026. PMID: 42613194. doi:10.1136/gutjnl-2026-339666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。